Skip to main content
Log in

Diagnostische Strategie und differenzialtherapeutisches Vorgehen bei zystischen Läsionen des Pankreas

Diagnostic strategy and differential therapeutic approach for cystic lesions of the pancreas

  • Leitthema
  • Published:
Der Radiologe Aims and scope Submit manuscript

Zusammenfassung

Klinisches/methodisches Problem

Zystische Pankreasläsionen (ZPL) werden zunehmend häufiger diagnostiziert. Da bis zu 60 % der ZPL als prämaligne oder maligne einzustufen sind, sollte jede ZPL diagnostisch abgeklärt werden. Seröse ZPL mit geringem Entartungsrisiko (serös zystische Neoplasien, SZN) müssen von muzinösen ZPL mit relevantem Malignitätspotenzial (intraduktale papillär-muzinöse Neoplasien [IPMN] und muzinös zystische Neoplasie [MZN]) und harmlosen Pseudozysten unterschieden werden.

Radiologische Standardverfahren

Die Schnittbildgebung mithilfe der CT und MRT spielt bei der Diagnostik von ZPL eine entscheidende Rolle.

Methodische Innovationen

Vorgestellt wird ein Algorithmus zur differenzialdiagnostischen Einordnung von ZPL.

Leistungsfähigkeit

Der Ganganschluss ist das entscheidende diagnostische Kriterium, um IPMN von den übrigen ZPL zu differenzieren. Eine Ausnahme stellt die Pseudozyste dar, die ebenfalls einen Ganganschluss aufweisen kann. ZPL ohne Ganganschluss lassen sich anhand morphologischer Kriterien und Korrelation des radiologischen Befundes mit Patientenalter, -geschlecht, Anamnese und klinischer Symptomatik weiter klassifizieren.

Empfehlung für die Praxis

Abhängig von der Diagnose und damit dem Malignitätsrisiko muss im interdisziplinären Konsens entschieden werden, ob die ZPL kontrolliert oder operiert werden sollte. Aufgrund ihres hervorragenden Weichteilkontrasts ist die MRT der CT bei der Abbildung morphologischer Eigenschaften von ZPL überlegen.

Abstract

Clinical/methodical issue

Cystic pancreatic lesions (CPL) are diagnosed with increasing frequency. Because up to 60 % of CPL are classified as malignant or premalignant, every CPL should be fully investigated and clarified. Serous CPL with low risk of malignancy must be differentiated from mucinous CPL with relevant potential malignancy (intraductal papillary mucinous neoplasm IPMN) and mucinous cystic neoplasm (MCN) as well as from harmless pseudocysts.

Standard radiological methods

Cross-sectional imaging with computed tomography (CT) and magnetic resonance imaging (MRI) plays a crucial role in the diagnostics of CPL.

Methodical innovations

An algorithm for the differential diagnostic classification of CPL is presented.

Performance

The connection to the pancreatic duct is the key diagnostic criterion to differentiate IPMN from all other CPL. An exception to this rule is that pseudocysts can also show a connection to the pancreatic duct. A further classification of CPL with no connection to the pancreatic duct can be made by morphological criteria and correlation of the radiological findings with patient age, sex, history and symptoms.

Practical recommendations

Depending on the diagnosis and hence the malignant potential the indications for surgery or watch and wait have to be discussed in an interdisciplinary cooperation. Due to its higher soft tissue contrast MRI is often superior to CT for depiction of CPL morphology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Abbreviations

CEA:

Karzinoembryonales Antigen

CP:

Chronische Pankreatitis

EUS:

Endoskopischer Ultraschall, Endosonographie

FNA:

Feinnadelaspiration

IPMN:

Intraduktal papillär muzinöse Neoplasien

MRCP:

Magnetresonanzcholangiopankreatikographie

MZ(C)N:

Muzinös zystische Neoplasie

NEPN:

Neuroendokrine Pankreasneoplasie

SPN:

Solide pseudopapilläre Neoplasie

SZN:

Serös zystische Neoplasie

VHL:

Von-Hippel-Lindau-Syndrom

ZPL:

Zystische Pankreasläsion

Literatur

  1. Bordeianou L, Vagefi PA, Sahani D et al (2008) Cystic pancreatic endocrine neoplasms: a distinct tumor type? J Am Coll Surg 206:1154–1158

    Article  PubMed  Google Scholar 

  2. Bosman FCF, Hruban R, Theise N (2010) WHO Classification of Tumours of the Digestive System. IARC Press, Lyon

    Google Scholar 

  3. Buerke B, Domagk D, Heindel W et al (2012) Diagnostic and radiological management of cystic pancreatic lesions: important features for radiologists. Clin Radiol 67:727–737

    Article  CAS  PubMed  Google Scholar 

  4. Campbell F, Azadeh B (2008) Cystic neoplasms of the exocrine pancreas. Histopathology 52:539–551

    Article  CAS  PubMed  Google Scholar 

  5. De Lima JE Jr, Javitt MC, Mathur SC (1999) Mucinous cystic neoplasm of the pancreas. Radiographics 19:807–811

    Article  PubMed  Google Scholar 

  6. Del Chiaro M, Verbeke C, Salvia R et al (2013) European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 45:703–711

    Article  PubMed  Google Scholar 

  7. Emuron D, Senadhi V, Teagarden S et al (2012) Pancreatic cysts: a systematic approach and second look. J Gastrointest Cancer 43:526–531

    Article  PubMed  Google Scholar 

  8. Fritz S, Klauss M, Bergmann F et al (2014) Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg 260:848–855 (discussion 855–856)

    Article  PubMed  Google Scholar 

  9. Fritz S, Schirren M, Klauss M et al (2012) Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery 152:S74–S80

    Article  PubMed  Google Scholar 

  10. Ganeshan DM, Paulson E, Tamm EP et al (2013) Solid pseudo-papillary tumors of the pancreas: current update. Abdom Imaging 38:1373–1382

    Article  PubMed  Google Scholar 

  11. Gore RM, Wenzke DR, Thakrar KH et al (2012) The incidental cystic pancreas mass: a practical approach. Cancer Imaging 12:414–421

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hackert T, Fritz S, Buchler MW (2015) Main- and branch-duct Intraductal papillary mucinous neoplasms: extent of surgical resection. Viszeralmedizin 31:38–42

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jais B, Rebours V, Malleo G et al (2015) Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. doi:10.1136/gutjnl-2015-309638

    Google Scholar 

  14. Jones MJ, Buchanan AS, Neal CP et al (2013) Imaging of indeterminate pancreatic cystic lesions: a systematic review. Pancreatology 13:436–442

    Article  CAS  PubMed  Google Scholar 

  15. Jr CM, Dixon E (2010) Intraductal papillary mucinous neoplasm: coming of age. World J Gastrointest Surg 2:299–305

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kalb B, Sarmiento JM, Kooby DA et al (2009) MR imaging of cystic lesions of the pancreas. Radiographics 29:1749–1765

    Article  PubMed  Google Scholar 

  17. Khan A, Khosa F, Eisenberg RL (2011) Cystic lesions of the pancreas. AJR Am J Roentgenol 196:W668–W677

    Article  PubMed  Google Scholar 

  18. Kim YC, Choi JY, Chung YE et al (2010) Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions. AJR Am J Roentgenol 195:947–952

    Article  PubMed  Google Scholar 

  19. Law JK, Ahmed A, Singh VK et al (2014) A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas 43:331–337

    Article  PubMed  Google Scholar 

  20. Lerch MM, Stier A, Wahnschaffe U et al (2009) Pancreatic pseudocysts: observation, endoscopic drainage, or resection? Dtsch Arztebl Int 106:614–621

    PubMed  PubMed Central  Google Scholar 

  21. Macari M, Finn ME, Bennett GL et al (2009) Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris. Radiology 251:77–84

    Article  PubMed  Google Scholar 

  22. Marchegiani G, Mino-Kenudson M, Ferrone CR et al (2015) Patterns of Recurrence After Resection of IPMN: Who, When, and How? Ann Surg 262(6):1108–1114

    Article  PubMed  Google Scholar 

  23. Morana G, Guarise A (2006) Cystic tumors of the pancreas. Cancer Imaging 6:60–71

    Article  PubMed  PubMed Central  Google Scholar 

  24. Palmucci S, Trombatore C, Foti PV et al (2014) The utilization of imaging features in the management of intraductal papillary mucinous neoplasms. Gastroenterol Res Pract 2014:765451

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sahani DV, Kadavigere R, Saokar A et al (2005) Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 25:1471–1484

    Article  PubMed  Google Scholar 

  26. Sahani DV, Kambadakone A, Macari M et al (2013) Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol 200:343–354

    Article  PubMed  Google Scholar 

  27. Salvia R, Festa L, Butturini G et al (2004) Pancreatic cystic tumors. Minerva Chir 59:185–207

    CAS  PubMed  Google Scholar 

  28. Sun HY, Kim SH, Kim MA et al (2010) CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification. Eur J Radiol 75:e45–e55

    Article  PubMed  Google Scholar 

  29. Sunkara S, Williams TR, Myers DT et al (2012) Solid pseudopapillary tumours of the pancreas: spectrum of imaging findings with histopathological correlation. Br J Radiol 85:e1140–e1144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Tanaka M, Fernandez-Del CC, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197

    Article  PubMed  Google Scholar 

  31. Zaheer A, Pokharel SS, Wolfgang C et al (2013) Incidentally detected cystic lesions of the pancreas on CT: review of literature and management suggestions. Abdom Imaging 38:331–341

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Klauß.

Ethics declarations

Interessenkonflikt

P. Mayer, C. Tjaden und M. Klauß geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mayer, P., Tjaden, C. & Klauß, M. Diagnostische Strategie und differenzialtherapeutisches Vorgehen bei zystischen Läsionen des Pankreas. Radiologe 56, 338–347 (2016). https://doi.org/10.1007/s00117-016-0091-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00117-016-0091-0

Schlüsselwörter

Keywords

Navigation